Clinical Trial Update: Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial in Japan evaluated the efficacy and safety of adding alogliptin to an alpha-glucosidase inhibitor in adults with Type 2 diabetes; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Acarbose (acarbose)
• Alogliptin (alogliptin)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2011-07-11